ReDirection - Self Help Program for Individuals with Sexual Interest in Children

NCT ID: NCT06133569

Last Updated: 2024-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-27

Study Completion Date

2024-10-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall aim of the study is to evaluate the effectiveness of the ReDirection program for individuals with low or medium risk to commit child sexual abuse.

Primary question: Is ReDirection a feasible, effective, and safe method in reducing low to medium risk participants' use of CSAM and related behaviors?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The present research project aims to contribute to the further development of accessible, evidence-based and safe care for people with concerns about their sexual interest regarding children, and that are using child sexual abuse material (CSAM), so that these people can access treatment according to their needs and level of risk, with the objective of reducing the risk for child sexual abuse and improving the health of the group.

More concretely, we aim to evaluate a revised version of an already available cognitive-behavioral self-help program, ReDirection, with the aim of testing whether this intervention can reduce sexual interest regarding children and CSAM use, in a group of people assessed as being at low or medium risk of committing sexual abuse of children. The intervention will be available in seven languages and will be tested in six countries.

Primary research question: Is ReDirection a feasible, effective, and safe method in reducing low to medium risk participants' use of CSAM and related behaviors?

Secondary research questions: Is ReDirection effective in reducing research subjects' overall risk of committing sexual acts involving children? Does ReDirection reduce specific dynamic risk factors for committing CSA?

ReDirection is based on cognitive behavioral therapy and consists of five modules. The program aims to help participants reduce their CSAM use by gaining a better understanding of, and skills to manage risky sexual thoughts, feelings, and behaviors. At the end of the program, participants are offered an anonymous follow-up chat and if needed during the program, participants can contact a practitioner via chat.

Research subjects will be recruited through Darknet and Clearnet. Darknet refers to websites that are accessible via TOR or similar services. The interventions are provided by practitioners and researchers in the relevant countries.

ReDirection will be evaluated through an international multicenter study using randomized wait-list controlled design.

The research subjects will sign a written consent form on the Iterapi platform without disclosing personal data such as name or location. During the subsequent screening interview via chat or voice call on Iterapi, participation criteria are ensured, questions are answered, and the consent to participate is confirmed. The research subjects are thus admitted to the study.

After inclusion, participants answer the baseline survey which consists of validated self-assessment questionnaires with both multiple choice and free-text answers.

Weekly during, after the waitlist, and after the therapeutic intervention, research subjects answer questions to evaluate the effectiveness and safety of the interventions.

A Statistical Analysis Plan (SAP) based on pilot study is pre-registered at the OSF platform. The SAP describes sample size calculations, and planned analyses of outcome measures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Child Abuse Sexual Pedophilia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Participants are allocated to either the ReDirection intervention or waitlist during the initial phase of the study and those who receive waitlist receive ReDirection during the second phase of the study.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ReDirection

ReDirection is a self help program based on cognitive behavioral therapy methodology and consists of five modules. The program aims to help participants reduce their CSAM use by gaining a better understanding of, and skills to manage risky sexual thoughts, feelings, and behaviors.

Group Type EXPERIMENTAL

ReDirection

Intervention Type BEHAVIORAL

Self help program based on principles for cognitive behavioral therapy

Waitlist

Participants are on a waitlist which means they have no active intervention, only weekly measurements with the same questionnaires as in the active arm.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ReDirection

Self help program based on principles for cognitive behavioral therapy

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sufficient language skills: English, Swedish, Finnish, Czech, Slovak, German, or Spanish
* concern about sexual interest regarding children\*,
* CSAM use past six month
* Low to medium risk for committing child sexual abuse according to the SChiMRA scale

Exclusion Criteria

\- Participants with a severe psychiatric illness (such as high acute suicide risk or severe substance abuse) will be excluded, or lack of serious intentions to participate.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre for Psychiatry Research, Region Stockholm, Sweden

UNKNOWN

Sponsor Role collaborator

Linkoeping University

OTHER_GOV

Sponsor Role collaborator

Universitat Jaume I, Spain

UNKNOWN

Sponsor Role collaborator

Protect Children Organisation, Finland

UNKNOWN

Sponsor Role collaborator

National Institute of Mental Health, Czech Republic

OTHER

Sponsor Role collaborator

Academy of the Police Force, Bratislava, Slovakia

UNKNOWN

Sponsor Role collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

Sponsor Role collaborator

Karolinska Institutet

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christoffer Rahm

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Institute of Mental Health

Klecany, , Czechia

Site Status RECRUITING

Protect Children NGO

Helsinki, , Finland

Site Status RECRUITING

[University Medical Center Hamburg-Eppendorf

Hamburg, , Germany

Site Status RECRUITING

Bratislava Police Academy

Bratislava, , Slovakia

Site Status RECRUITING

Universitat Jaume I

Castelló, , Spain

Site Status RECRUITING

Centre for psychiatry research, Region Stockholm

Stockholm, , Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Czechia Finland Germany Slovakia Spain Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christoffer Rahm, MD, PhD

Role: CONTACT

+46793393723

Maria Breide

Role: CONTACT

+46735563825

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Katerina Klapilova, Ass Professor

Role: primary

Nina Vaarhanen-Valkonen

Role: primary

Peer Briken, Professor

Role: primary

Josef Metenko, Professor

Role: primary

Rafael Ballester, Professor

Role: primary

Christoffer Rahm, MD PhD

Role: primary

+46793393723

Christoffer Rahm, MD PhD

Role: backup

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

101084355-BRIDGE-ISF-2021

Identifier Type: OTHER

Identifier Source: secondary_id

2023-02321-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treating Adolescents With CBT and OBH
NCT04760938 TERMINATED NA